1 2 3 4 5 Next
New NY Senator Makes First Visit to WNY
New York's new senator makes her first trip to Western New York since her appointment, to talk about issues important to this end of the state. She may have only been in town for a few hours, but she characterized her meeting with local leaders as "extremely productive." (Sun, 01 Feb 2009 00:17:40 GMT)
BUSAC Discussion Session: "Genomics and the Future of Medicine"
At 2 p.m. on Thursday, February 5, in Baxter Lecture Hall, a discussion session called "Genomics and the Future of Medicine" will feature Francis S. Collins, former director of the National Human Genome Research Institute (NHGRI) at the National Institutes of Health, and Nobel Laureate David Baltimore, Caltech's president emeritus and Millikan Professor of Biology. Admission is free, and no ... (Sun, 01 Feb 2009 08:09:44 GMT)
The week: Stories and photos from January 25-31
Pentagon officials have toured the brig at Camp Pendleton as they consider moving Guantanamo Bay detainees there, to the prison at Miramar Marine Corps Air Station and to other facilities, a local congressman said Monday. (Sun, 01 Feb 2009 10:03:25 GMT)
Gillibrand courts constituents in area
Buffalo met New York's new U. S. senator, Kirsten E. Gillibrand, for the first time Saturday amid the gleaming new research facilities of the Buffalo Niagara Medical Campus. (Sun, 01 Feb 2009 12:13:39 GMT)
Gillibrand courts constituents in area
Buffalo met New York's new U. S. senator, Kirsten E. Gillibrand, for the first time Saturday amid the gleaming new research facilities of the Buffalo Niagara Medical Campus. (Sun, 01 Feb 2009 13:03:52 GMT)
New technology discovery at Mount Sinai Hospital holds promise for improved breast cancer treatment
( Samuel Lunenfeld Research Institute ) In a study published by Nature Biotechnology online on Feb. 1, 2009, Mount Sinai Hospital researchers have unveiled a new technology tool that analyzes breast cancer tumors to determine a patient's best treatment options. The tool can predict with more than 80 percent accuracy a patient's chance of recovering from breast cancer. (Sun, 01 Feb 2009 18:12:34 GMT)
Scientists uncover new class of non-protein coding genes in mammals with key functions
( Broad Institute of MIT and Harvard ) Researchers have uncovered a vast new class of previously unrecognized mammalian genes that do not encode proteins, but instead function as long RNA molecules, and seem to play critical roles in both health and disease, including cancer, immune signaling and stem cell biology. (Sun, 01 Feb 2009 18:12:44 GMT)
New Promise For Improved Breast Cancer Treatment
Researchers have unveiled a new technology tool that analyzes breast cancer tumors to determine a patient's best treatment options. The tool can predict with more than 80 percent accuracy a patient's chance of recovering from breast cancer. (Sun, 01 Feb 2009 20:34:20 GMT)
Expression Data May Help Weed Disease-Relevant SNPs Out of GWAS Data, Study Suggests
NEW YORK (GenomeWeb News) – Genetic variants influencing disease risk are more likely to occur in differentially expressed genes, according to a team of researchers who have developed a tool, dubbed functionally interpolating SNPs, or fitSNPs, for prioritizing candidate loci discovered during genome-wide association studies. (Sun, 01 Feb 2009 23:38:08 GMT)
Ingenuity’s IPA to Act as Integration Core For Huntington’s-Specific CHDI Project
Following a year of evaluation , Huntington’s disease research organization CHDI has selected the Ingenuity Pathway Analysis system to serve as the foundation for a disease-specific research informatics platform it is developing for internal use. (Sun, 01 Feb 2009 23:38:18 GMT)
Key To Pre-eclampsia May Be Found In Misfolded Proteins In Urine
Clues to the cause of pre-eclampsia, a common, but serious hypertension complication of pregnancy that has puzzled doctors and researchers for decades, point to proteins that misfold and aggregate, according to researchers. (Mon, 02 Feb 2009 04:34:39 GMT)
Genetic Blueprint Of Sorghum -- Key Food And Biofuels Crop -- Completed
Scientists have completed the sequence and analysis of the complete genome of sorghum, a major food and fodder plant with high potential as a bioenergy crop. The genome data will aid scientists in optimizing sorghum and other crops not only for food and fodder use, but also for biofuels production. (Mon, 02 Feb 2009 04:34:50 GMT)
Stephen Wong Named John S. Dunn Distinguished Endowed Chair in Biomedical Engineering at Methodist Hospital
Dr. Wong's research combines genomics with advanced imaging and biosensing techniques for more personalized medical care. His goal is to take the guess work out of treatment decisions, saving cost and time, both of which are precious commodities for patients with cancer or neurodegenerative diseases. (Mon, 02 Feb 2009 05:27:09 GMT)
Vascular drug found to improve learning and memory in middle-aged rats
( American Psychological Association ) A team of Arizona psychologists, geneticists and neuroscientists has reported that a safe and effective drug used to treat vascular problems in the brain has improved spatial learning and working memory in middle-aged rats. Although far from proving anything about human use of the drug, the finding supports the scientific quest for a substance that could ... (Mon, 02 Feb 2009 05:33:49 GMT)
Arizona research team gathers valuable memory-drug data
Study suggests high doses of a drug called Fasudil improved learning and memory in lab rats. (Mon, 02 Feb 2009 06:58:53 GMT)
Fox Chase Cancer Center's Keystone Program in Blood Cell Development and Cancer Adopts BioDiscovery's Nexus Copy ...
BioDiscovery Inc., the leading developer of integrated software solutions for microarray-based research, announced today that Fox Chase Cancer Center's Keystone Program in Blood Cell Development and Cancer has acquired a site license for Nexus Copy Number and Nexus Expression, two companion tools designed specifically for scientists working on DNA copy number and RNA expression analysis from ... (Mon, 02 Feb 2009 07:01:00 GMT)
My Pharmiweb.com
AnaSpec Inc. AnaSpec, Inc., a leading provider of integrated proteomics solutions, today announced that the U.S. Patent and Trademark Office has issued the company patent number 7,465,810 for “Reactive 1,3’-Crosslinked Carbocyanines and Their Bioconjugates.” (Mon, 02 Feb 2009 10:21:49 GMT)
Global warming spurs drive for drought resistant cereal
London, Feb 2 : Global warming is prompting the drive for drought and heat resistant cereal, which can be grown in the most arid areas to take care of some of our food requirements. (Mon, 02 Feb 2009 10:34:29 GMT)
Your Family May Once Have Been A Different Color
Skin pigmentation in human lineages has changed much faster and more frequently than scientists previously thought, says anthropologist Nina Jablonski. The researcher says that a population can be one color (light or dark), and 100 generations later — with no intermarriage — be a very different color. (Mon, 02 Feb 2009 11:27:13 GMT)
Queensland Facility for Advanced Bioinformatics (QFAB) Becomes a GeneGo Center of Excellence for the Asia Pacific Region
GeneGo, Inc., the leading systems biology tools company, announced today that QFAB has licensed MetaCore and entered a co marketing agreement with GeneGo for the Asia Pacific region. (Mon, 02 Feb 2009 12:00:00 GMT)
Agilent Technologies and National University of Ireland, Galway, Open Biological Mass Spectrometry Facility
SANTA CLARA, Calif. & GALWAY, Ireland----Agilent Technologies Inc. and the National University of Ireland , Galway, today announced the opening of a Biological Mass Spectrometry Facility on the NUI Galway campus. (Mon, 02 Feb 2009 12:00:00 GMT)
Misfolded Proteins In The Urine May Provide Key To Pre-Eclampsia
Clues to the cause of preeclampsia, a common, but serious hypertension complication of pregnancy that has puzzled doctors and researchers for decades, point to proteins that misfold and aggregate, according to Yale School of Medicine researchers. (Mon, 02 Feb 2009 12:07:20 GMT)
Agilent Technologies and National University of Ireland, Galway, Open Biological Mass Spectrometry Facility
Agilent Technologies Inc. (NYSE:A) and the National University of Ireland (NUI), Galway, today announced the opening of a Biological Mass Spectrometry Facility on the NUI Galway campus. The state-of-the-art facility is fully equipped with the latest accurate-mass quadrupole time-of-flight (Q-TOF) and triple quadrupole (QQQ) mass spectrometer platforms from Agilent. (Mon, 02 Feb 2009 12:21:30 GMT)
Potential For Improved Breast Cancer Treatment Using New Technology Discovery At Mount Sinai Hospital
In a study published by Nature Biotechnology online on February 1, 2009, Mount Sinai Hospital researchers have unveiled a new technology tool that analyzes breast cancer tumours to determine a patient's best treatment options. The tool can predict with more than 80 per cent accuracy a patient's chance of recovering from breast cancer. (Mon, 02 Feb 2009 13:05:59 GMT)
Bioalma Introduces novo|seek Intelligent Search Resource for Life Sciences Community
Biomedical research and studies are critical to the implementation of new basic research, as it is for the development of new medicines. With the vastness of research data available today – estimated at 18 million documents across more than 20,000 medical journals – it is imperative that the research community have easy access to the latest research information available. (Mon, 02 Feb 2009 13:27:23 GMT)
Genomics Workstation provides automated liquid handling.
Designed for molecular biology applications, Zephyr Genomics Workstation includes pre-installed methods for automating nucleic acid purification chemistries, as well as standard Caliper methods for routine applications such as PCR setup and sample normalization. With partial tip loading capability, instrument can process 8-96 samples simultaneously. Unit's ultrasonic detector provides ... (Mon, 02 Feb 2009 13:53:03 GMT)
TGen and ASU researchers find drug that could reduce risk of Alzheimer's
( The Translational Genomics Research Institute ) A drug used to improve blood flow to the brain also could help improve learning and memory and reduce the risk of Alzheimer's disease, according to a new study released today by investigators at the Translational Genomics Research Institute (TGen) and Arizona State University. (Mon, 02 Feb 2009 14:13:04 GMT)
New vaccine R&D collaboration between Singapore's institute and GlaxoSmithKline Biologicals
( Agency for Science, Technology and Research (A*STAR), Singapore ) Singapore's Bioprocessing Technology Institute and GlaxoSmithKline Biologicals SA Belgium have sealed an agreement to collaborate in three vaccine and adjuvant system related research projects. Adjuvants are compounds used together with vaccines to boost a person's immune responses. (Mon, 02 Feb 2009 14:46:43 GMT)
Key To Preeclampsia May Be Found In Misfolded Proteins In The Urine
Clues to the cause of preeclampsia, a common, but serious hypertension complication of pregnancy that has puzzled doctors and researchers for decades, point to proteins that misfold and aggregate, according to Yale School of Medicine researchers. (Mon, 02 Feb 2009 15:06:26 GMT)
NUI Opening Mass Spec Facility Using Agilent Instruments
NEW YORK (GenomeWeb News) – Agilent Technologies today announced the opening of a mass spectrometry facility focused on functional genomics, proteomics, lipidomics, and metabolomics research on the National University of Ireland's Galway campus. (Mon, 02 Feb 2009 15:23:29 GMT)
Roche Extends Genedata License
NEW YORK (GenomeWeb News) — Roche has extended a license agreement with Genedata for the Refiner mass spectrometry module of the Expressionist biomarker platform, Genedata said today. (Mon, 02 Feb 2009 15:24:49 GMT)
Sorenson Forensics Sees 2008 Revenues Rise 240 Percent While Creating Programs to Empower Clients in Fast-Growing DNA ...
Sorenson Forensics today announced its gross revenues increased 240 percent in 2008 over the previous year. The independent business unit of Sorenson Genomics found increased profits by offering innovative programs to law enforcement, public crime labs, courts and private labs that helped these clients meet an increasing demand for timely and accurate forensic DNA services. (Mon, 02 Feb 2009 15:41:50 GMT)
Darwin, Reviewed
In the New York Times Sunday Book Review , Christopher Benfey reviews two new books on Charles Darwin . According to Benfey, Adrian Desmond and James Moore say in Darwin's Sacred Cause: How a Hatred of Slavery Shaped Darwin's Views on Human Evolution that Darwin argued "for the unitary origin and hence 'brotherhood' of all human beings." (Mon, 02 Feb 2009 16:53:10 GMT)
It's Not Just Americans
The Rescuing Darwin survey, found that half of British adults do not believe in evolution , reports the UK's Guardian . The poll found that one-quarter of British adults say that the theory of evolution is "definitely true" and another quarter say it is "probably true." (Mon, 02 Feb 2009 16:53:20 GMT)
From Lab Rat to Librarian
A blogger at Bitesize Bio tells the tale of how she went from aspiring scientific researcher to librarian . Her job includes everything from teaching workshops on clinical genetics to managing a web site and curating a bioinformatics database. (Mon, 02 Feb 2009 16:53:30 GMT)
Doctors No Longer Have to Feel Left Out
ScienceRoll's Bertalan Meskó has launched PeRSSonalized Medicine , a new online tool for time-strapped doctors who need to keep up with the literature but don't have time, or don't know much about Web 2.0 tools. (Mon, 02 Feb 2009 16:53:40 GMT)
Cognitive Ability of Aging Senior Citizens May Be Enhanced by Blood Flow Regulating Drug
Feb. 2, 2009 - A drug used to improve blood flow to the brain also could help improve learning and memory and reduce the risk of Alzheimer's disease for seniors, according to a new study released today by investigators at the Translational Genomics Research Institute (TGen) and Arizona State University. (Mon, 02 Feb 2009 16:59:29 GMT)
The Hospital for Sick Children Selects GenoLogics for Integrated Lab and Data Management Solution
Vancouver, BC, February 2, 2009--(T-Net)--GenoLogics announced that The Centre for Applied Genomics at The Hospital for Sick Children is deploying its lab and data management solution across multiple facilities of its genome centre. (Mon, 02 Feb 2009 17:17:09 GMT)
Predicting the Course
Canadian researchers found that determining how different proteins interact in tumors can be used to predict a woman's chances at surviving breast cancer . As they report in Nature Biotechnology , scientists led by the University of Toronto's Jeffrey Wrana first scoured the literature for proteins that interact with many other proteins and then looked at genome-wide expression from 79 human ... (Mon, 02 Feb 2009 17:23:13 GMT)
MJM Bites the Dust
"A pioneering medical journal has fallen victim to the dramatic and wrenching changes that are overtaking the publishing industry," says a 60-Second Science story at Scientific American : the Medscape Journal of Medicine has closed shop. (Mon, 02 Feb 2009 17:38:09 GMT)
Cambridge University Research Group Employs Fluidigm’s EP1 System for Cancer and Disease Association Studies
Fluidigm Corporation today announced that the Cancer Research UK Centre for Genetic Epidemiology, University of Cambridge, based at Strangeways Research Laboratory in the United Kingdom, has purchased the company’s EP1 System to conduct cancer research and disease association studies. The Fluidigm EP1 system combines the efficiencies of integrated fluidic circuit (IFC)-based high-throughput ... (Mon, 02 Feb 2009 18:21:25 GMT)
Can bacteria rescue the oil industry?
Microbes in oil deposits withstand enormous hydrocarbon loads, intense heat, high salt and immense pressure. How can we put them to work for us? (Mon, 02 Feb 2009 18:27:23 GMT)
New Senator Kirsten Gillibrand Meets with WNY Leaders
The state's newest senator visited Western New York Saturday and met with approximately 100 of the region's community leaders. Senator Kirsten Gillibrand (D-NY) held the roundtable discussion at the Center of Excellence in Bioinformatics and Life Sciences on the Buffalo Niagara Medical Campus. (Mon, 02 Feb 2009 19:11:38 GMT)
New Senator Kirsten Gillibrand Meets with WNY Leaders
The state's newest senator visited Western New York Saturday and met with approximately 100 of the region's community leaders. Senator Kirsten Gillibrand (D-NY) held the roundtable discussion at the Center of Excellence in Bioinformatics and Life Sciences on the Buffalo Niagara Medical Campus. (Mon, 02 Feb 2009 19:11:57 GMT)
New vaccine developed for preventing 'uncommon cold' virus
( George Mason University ) Common colds typically cause a week of sneezing, aches and pains and then fade away leaving only a sore nose and a few used sick days behind. But what if that cold turned out to be something more? (Mon, 02 Feb 2009 19:13:15 GMT)
Comparative genomics reveals molecular evolution of Q fever pathogen
( Virginia Tech ) In the year of the 200th anniversary of the birth of Darwin, researchers have uncovered genetic clues about why some strains of the pathogen that causes Q fever, Coxiella burnetii, are more virulent than others. (Mon, 02 Feb 2009 20:47:24 GMT)
Boehringer Ingelheim, Cenix in RNAi Research Deal
NEW YORK (GenomeWeb News) — Cenix BioScience will support Boehringer Ingelheim with RNAi-focused contract research services for its therapeutic drug programs under a new agreement, Cenix said today. (Mon, 02 Feb 2009 20:53:26 GMT)
Fluorotechnics Rebrands as Gelcompany
NEW YORK (GenomeWeb News) – Fluorotechnics, a Sydney, Australia-based supplier of fluorescence and other protein detection technologies, today said that it has rebranded itself under the name of a firm it acquired last year, Gelcompany. (Mon, 02 Feb 2009 20:53:28 GMT)
Proxeon Raises $2.4M from VC Investors
NEW YORK (GenomeWeb News) – Danish proteomics firm Proxeon has raised DKK14 million ($2.4 million) in a round of private financing from venture capital investors. (Mon, 02 Feb 2009 20:53:38 GMT)
DuPont Licenses DxS Multiplex Assay Technology
NEW YORK (GenomeWeb News) — DuPont's Qualicon business has licensed DxS' Scorpion multiplex assay platform for use in developing diagnostic tests for the food industry. (Mon, 02 Feb 2009 20:53:58 GMT)
Comparative genomics reveals molecular evolution of Q fever pathogen
Scientists from the National Institute of Allergy and Infectious Diseases, Texas A&M Health Center, and the Virginia Bioinformatics Institute at Virginia Tech have uncovered genetic clues about why some strains of the pathogen Coxiella burnetii are more virulent than others. (Mon, 02 Feb 2009 20:58:13 GMT)
Strategic Diagnostics Appoints Monette Greenway as Vice President, Marketing and Sales
Strategic Diagnostics Inc. (Nasdaq: SDIX) – today announced key additions to its management team of two experienced professionals from the Life Sciences market. Monette Greenway was appointed Vice President, Marketing and Sales effective January 28, 2009, and Robert Laffer joined SDI as Sales Manager for Life Sciences effective January 15, 2009. (Mon, 02 Feb 2009 21:27:38 GMT)
Cold Spring Harbor Protocols features stem cell differentiation, plant RNAi methods
( Cold Spring Harbor Laboratory ) This month's issue of "Cold Spring Harbor Protocols" highlights methods involving RNA interference in plants and stem cell differentiation. (Mon, 02 Feb 2009 21:49:49 GMT)
Fox Chase Licenses Bioinformatics Tools from BioDiscovery
NEW YORK (GenomeWeb News) – Fox Chase Cancer Center's Keystone Program in Blood Cell Development and Cancer has acquired a site license for two bioinformatics software programs from BioDiscovery. (Mon, 02 Feb 2009 22:08:09 GMT)
Study: racial profiling no more effective than random screen
One of the larger problems facing the security industry in the era of mass terrorism is the task of creating a profile of a likely terrorist. Identifying those at risk of first time offenses is a challenge in any context, but the stakes are higher when that offense may also be the last, and involve the deaths of dozens of people. We've discussed the challenges of generating profiles of ... (Mon, 02 Feb 2009 22:11:29 GMT)
PerkinElmer to Divest Proteomics Business to Concentrate on Human, Environmental Health
PerkinElmer plans to divest its proteomics product line and intends to focus instead on developing screening and diagnostic tools and technologies for food safety and security applications, the company said last week. (Mon, 02 Feb 2009 22:23:19 GMT)
At the Forefront: Epigenomics Heats Up
Move over, Mendel. The age of epigenomics is here, and it's provoking a lot of interesting questions. (Mon, 02 Feb 2009 23:38:41 GMT)
The Father of Cell Biology Has Died
Nobel laureate and one of the founding fathers of modern cell biology, George Palade, has died at 95. He was one of the first to use electron microscopy, which helped him discover the ribosome and the action of secretory proteins. (Mon, 02 Feb 2009 23:39:01 GMT)
AnaSpec Awarded Patent for HiLyte FluorTM Dyes
AnaSpec, Inc. today announced that the U.S. Patent and Trademark Office has issued the company patent number 7,465,810 for “Reactive 1,3’-Crosslinked Carbocyanines and Their Bioconjugates.” [PR.com - February 01, 2009] (Tue, 03 Feb 2009 03:50:48 GMT)
Leading futurists, thinkers to launch Silicon Valley university
Starting this summer, some of the world's leading thinkers in exponentially growing technologies will be gathering annually at NASA Ames Research Center, in the heart of Silicon Valley, for 10 weeks of discussions on how to change the future. And you could join them. (Tue, 03 Feb 2009 05:00:00 GMT)
Leading futurists, thinkers to launch Silicon Valley university
Dubbed Singularity University, the new program, run by Ray Kurzweil and Peter Diamandis, will focus on exponentially growing technologies. (Tue, 03 Feb 2009 05:11:05 GMT)
World-Renowned Scientists Team With Google And NASA To Launch Singularity University
NASA, Google, and some of the foremost authorities in science and technology have teamed up to create a new school, dubbed Singularity University , that is looking to solve "humanity's grand challenges". The university is named after the idea of the singularity - an extremely rapid period of technological progress. And damn if it doesn't sound like the coolest school ever. The roster ... (Tue, 03 Feb 2009 06:05:24 GMT)
Fasudil could reduce risk of Alzheimer's
A drug used to improve blood flow to the brain also could help improve learning and memory and reduce the risk of Alzheimer's disease, according to a new study released today by investigators at the Translational Genomics Research Institute (TGen) and Arizona State University. (Tue, 03 Feb 2009 09:03:53 GMT)
Bio-informatics can help in advancement of medical science
Shillong, Feb 3 : Bio Informatics can be of tremendous help in navigating through the sea of information, Meghalaya Governor R S Mooshahary said while calling for improvement in the quality of manpower in that field. (Tue, 03 Feb 2009 10:03:38 GMT)
A Singular(ity) School
Futurists create a place to study the fusion of ideas and science across disciplines. (Tue, 03 Feb 2009 10:22:57 GMT)
New genetic clues on molecular evolution of Q fever pathogen
Scientists from the National Institute of Allergy and Infectious Diseases, Texas A&M Health Center, and the Virginia Bioinformatics Institute at Virginia Tech have uncovered genetic clues about why some strains of the pathogen Coxiella burnetii are more virulent than others. (Tue, 03 Feb 2009 10:33:43 GMT)
Roche NimbleGen and 454 Life Sciences Capture the Targeted Resequencing Market on a Global Scale
MADISON, Wis.----Roche NimbleGen and 454 Life Sciences are capturing the targeted resequencing market as researchers in laboratories worldwide adopt the NimbleGen Sequence Capture microarrays and the Genome Sequencer FLX System to speed sample preparation and subsequent sequencing for research on genetic-based diseases such as cancer and diabetes. (Tue, 03 Feb 2009 13:00:00 GMT)
GSK To Commit $1.3 Million To Singapore Institute's Vaccine Development Projects
Singapore's Bioprocessing Technology Institute (BTI) and Glaxo SmithKline (GSK) Biologicals SA Belgium have sealed an agreement to collaborate in three vaccine and adjuvant system related research projects. Adjuvants are compounds used together with vaccines to boost a person's immune responses. (Tue, 03 Feb 2009 13:17:22 GMT)
Roche NimbleGen and 454 Life Sciences Capture the Targeted Resequencing Market on a Global Scale
Roche NimbleGen and 454 Life Sciences are capturing the targeted resequencing market as researchers in laboratories worldwide adopt the NimbleGen Sequence Capture microarrays and the Genome Sequencer FLX System to speed sample preparation and subsequent sequencing for research on genetic-based diseases such as cancer and diabetes. Targeted resequencing allows scientists to capture only the ... (Tue, 03 Feb 2009 13:34:27 GMT)
Photo Release -- Protea Releases New Proteomics Technology Platform
MORGANTOWN, W.Va., Feb. 3, 2009 -- Protea Biosciences, Inc., a leader in the development of new protein research technology, announced today the commercial launch of its new protein recovery technology platform, the GPR-800. (Tue, 03 Feb 2009 14:00:00 GMT)
Stroma genomic signature predicts resistance to anthracyclin-based chemotherapy in breast cancer
( Swiss Institute of Bioinoformatics ) Researchers at the Swiss Institute of Bioinformatics and the Swiss National Center of Competence in Research in Molecular Oncology in Lausanne have developed a new test to predict how breast cancer patients respond to chemotherapy, which could help change how treatment is delivered in the future. (Tue, 03 Feb 2009 14:12:45 GMT)
Prodesse Files for FDA OK for C. Difficile Assay
The Milwaukee, Wis.-based firm said that it had filed for 510(k) clearance of the ProGastro Cd Assay following clinical trials conducted at several clinical labs in the US. The assay is already being used for clinical diagnostics in Europe, and additional studies of the test are currently being conducted in the UK. (Tue, 03 Feb 2009 14:23:08 GMT)
Transgenomic Licenses Power3 Neuro Biomarkers
NEW YORK (GenomeWeb News) – Transgenomic said on Monday that it has finalized an agreement with Power3 Medical Products giving it rights to Power3' Medical's neurodegenerative biomarkers. (Tue, 03 Feb 2009 14:23:28 GMT)
Researchers ID Lung Cancer Prognostic Signatures
NEW YORK (GenomeWeb News) – In a paper scheduled to appear online this week in the Proceedings of the National Academy of Sciences , a team of Ontario researchers used a computer algorithm to come up with a new six-gene expression signature for predicting survival in non-small cell lung cancer that they subsequently validated in four datasets. (Tue, 03 Feb 2009 14:54:08 GMT)
Stroma Genomic Signature Predicts Resistance To Anthracyclin-based Chemotherapy In Breast Cancer
Researchers have developed a new test to predict how breast cancer patients respond to chemotherapy, which could help change how treatment is delivered in the future. (Tue, 03 Feb 2009 15:40:27 GMT)
Research and Markets: Plant Proteomics Out Now
DUBLIN, Ireland----Research and Markets has announced the addition of John Wiley and Sons Ltd's new report "Plant Proteomics" to their offering. (Tue, 03 Feb 2009 15:56:00 GMT)
Stroma genomic signature predicts resistance to anthracyclin-based chemotherapy in breast cancer
Researchers at the Swiss Institute of Bioinformatics and the Swiss National Center of Competence in Research in Molecular Oncology in Lausanne have developed a new test to predict how breast cancer patients respond to chemotherapy, which could help change how treatment is delivered in the future. In an article, 'A stroma-related gene signature predicts resistance to neoadjuvant chemotherapy in ... (Tue, 03 Feb 2009 16:10:57 GMT)
CORRECTING|and REPLACING Strategic Diagnostics Appoints Monette Greenway as Vice President, Marketing and Sales
NEWARK, Del.----Eight graph, second sentence of release dated Feb. 2, 2009, should read: Both the option and the restricted stock vest in four equal annual installments, beginning on the date of grant. (Tue, 03 Feb 2009 16:44:00 GMT)
New Kid on the Block
Yesterday, the Coriell Personalized Medicine Collaborative website went live . Unlike its personal genomics competitors, Coriell is offering a full genome scan plus a genetic health report and genetic counseling all for free. (Tue, 03 Feb 2009 16:53:19 GMT)
Finding Mutations that Protect
Technology Review has a Q&A with Ken Offit, chief of the clinical genetics service at Memorial Sloan-Kettering Cancer Center, who is leading a new study looking for protective variants in women with mutations in BRCA2. He hopes to use SNP arrays and a large number of study participants worldwide to find what factors might protect women who are genetically predisposed to getting breast cancer ... (Tue, 03 Feb 2009 17:08:09 GMT)
Reproductive Cloning in Sight?
A story in Wired looks at the possibility of human cloning. In a study led by Robert Lanza, scientific director of Advanced Cell Technologies, he showed that the genes turned on in normal human embryos are the same genes turned on in human clones. (Tue, 03 Feb 2009 17:08:19 GMT)
Drug That Could Reduce Risk Of Alzheimer's Discovered By TGen And ASU Researchers
A drug used to improve blood flow to the brain also could help improve learning and memory and reduce the risk of Alzheimer's disease, according to a new study released by investigators at the Translational Genomics Research Institute (TGen) and Arizona State University. (Tue, 03 Feb 2009 17:17:52 GMT)
NIH Funding for Proteomics Fall 3 Percent in FY 2008 as Number of Grants Slides 8 Percent
For the period covering Oct.1, 2007, to Sept. 30, 2008, the NIH handed out $125.6 million in grants for proteomics research, compared to $129.1 million in fiscal 2007. Meanwhile, 317 awards were handed out in 2008, down more than 8 percent from 346 grants given in 2007. In many, if not most, cases, funding received in 2008 were part of multi-year grants that began in earlier years. (Tue, 03 Feb 2009 18:53:10 GMT)
NIH Funding for Proteomics Fall 3 Percent in FY 2008 as Number of Grants Slides 8 Percent
For the period covering Oct.1, 2007, to Sept. 30, 2008, the NIH handed out $125.6 million in grants for proteomics research, compared to $129.1 million in fiscal 2007. Meanwhile, 317 awards were handed out in 2008, down more than 8 percent from 346 grants given in 2007. In many, if not most, cases, funding received in 2008 were part of multi-year grants that began in earlier years. (Tue, 03 Feb 2009 18:53:20 GMT)
Molecular Evolution Of Q Fever Pathogen Revealed
Scientists from the National Institute of Allergy and Infectious Diseases, Texas A&M Health Center, and the Virginia Bioinformatics Institute at Virginia Tech have uncovered genetic clues about why some strains of the pathogen Coxiella burnetii are more virulent than others. The researchers compared the sequences of four different strains of C. (Tue, 03 Feb 2009 19:16:42 GMT)
Helicos, Rosetta Shares Rose Sharply in January
NEW YORK (GenomeWeb News) – Shares of Helicos BioSciences and Rosetta Genomics rose more than 100 percent each during January to lead the 36 stocks that comprise the GenomeWeb Daily News Index. (Tue, 03 Feb 2009 20:23:14 GMT)
New Products
CLC Bio has released version 3.0 of CLC Genomics Workbench . The new version allows users to perform digital gene expression analyses, as well as analyses of expression microarray and RNA-Seq data. (Tue, 03 Feb 2009 20:23:40 GMT)
Paired Ends
An algorithm that researchers used to identify a new gene expression signature to predict lung cancer survival also suggests that there are thousands of such prognostic signatures in microarray data sets. (Tue, 03 Feb 2009 20:23:50 GMT)
Broad Institute to Cut Sequencing Staff
NEW YORK (GenomeWeb News) — The Broad Institute of MIT and Harvard will cut 24 employees from its Genome Sequencing Platform because new genomics technologies have made some staff unnecessary. (Tue, 03 Feb 2009 20:38:16 GMT)
BioArray Briefs
Fluidigm said this week that Cancer Research UK's Centre for Genetic Epidemiology, University of Cambridge, will use its EP1 system to conduct cancer research and disease-association studies. (Tue, 03 Feb 2009 20:38:46 GMT)
New Product Watch
Navigenics last week launched Annual Insight , a direct-to-consumer genetic testing service available for $499 that provides information on an individual’s genetic predisposition for common preventable health conditions. (Tue, 03 Feb 2009 20:38:54 GMT)
Funding Update
An algorithm that researchers used to identify a new gene expression signature to predict lung cancer survival also suggests that there are thousands of such prognostic signatures in microarray data sets. (Tue, 03 Feb 2009 20:39:05 GMT)
Gentel Prepares to Launch APiX Platform, Assays in H1 as It Looks to Build Services Arm
Gentel Biosciences, a nine-year-old privately held protein-array firm based in Madison, Wis., is planning to launch assays for carbohydrate and cancer-biomarker profiling this month, and to debut a new high-throughput microarray platform called APiX in June, according to a company official. (Tue, 03 Feb 2009 20:53:09 GMT)
Kreatech to Grow Product, Sales Efforts to Face Ever-Growing Molecular Cytogenetics Market
Encouraged by demand from molecular cytogeneticists for its fluorescent in situ hybridization probes and microarray labeling kits, Amsterdam-based Kreatech Diagnostics will add resources to its direct sales channels in Europe and is developing its own microRNA array product line, according to a company official. (Tue, 03 Feb 2009 20:53:19 GMT)
Illumina Reports Financial Results for Fourth Quarter and Fiscal Year 2008
Illumina, Inc. (NASDAQ:ILMN) today announced its financial results for the fourth quarter and fiscal year 2008. (Tue, 03 Feb 2009 21:20:30 GMT)
Google Backs Singularity University Vision for Leaders
After a year of working behind the scenes, technology veteran Ray Kurzweil has taken his research on singularity to the next level. Kurzweil, along with NASA's Peter Diamandis and a team of other top technologists, will launch Singularity University for leaders from all backgrounds to study singularity -- the theory that artificial intelligence will someday surpass human intelligence. (Tue, 03 Feb 2009 21:46:23 GMT)
AdvanDx Gets FDA OK for Dual Pathogens Test
NEW YORK (GenomeWeb News) – AdvanDx has received US Food and Drug Administration clearance for its E. coli/P. aeruginosa PNA FISH assay to identify Escherichia coli and/or Pseudomonas aeruginosa directly from positive blood cultures. (Tue, 03 Feb 2009 22:09:15 GMT)
The Worst Stem Cell of All
New York Times reports on a project set to kick off in the next few months in which three medical research centers -- the University of Michigan Comprehensive Cancer Center, Dana-Farber Cancer Institute, and Baylor College of Medicine -- will begin testing patients for the presence of cancerous stem cells to see if there's hope for therapeutically targeting them in the future. (Tue, 03 Feb 2009 23:53:09 GMT)
King Tut Gets a Paternity Test
Egyptian archaeologists will use DNA tests to see if mummified remains of two stillborn children found in the tomb of Tutankhamun are his children, reports the BBC . DNA samples from the two fetuses will be compared to each other and to Tutankhamun at Cairo University, and the results should be known by December. (Tue, 03 Feb 2009 23:53:19 GMT)
Don't Forget the Sunblock, Dear
Wolfgang Schreier is lead author on a paper in today's Science ($) in which a team of scientists report witnessing DNA being damaged as a result of exposure to UV light. (Tue, 03 Feb 2009 23:53:29 GMT)
Agilent Technologies And National University Of Ireland, Galway, Open Biological Mass Spectrometry Facility
Agilent Technologies Inc. and the National University of Ireland (NUI), Galway, today announced the opening of a Biological Mass Spectrometry Facility on the NUI Galway campus. The state-of-the-art facility is fully equipped with the latest accurate-mass quadrupole time-of-flight (Q-TOF) and triple quadrupole (QQQ) mass spectrometer platforms from Agilent. The facility primarily focuses on ... (Wed, 04 Feb 2009 06:28:13 GMT)
Chronic drinking more harmful for liver than acute or binge drinking
Washington, Feb 4 : A new study on rodents has revealed that chronic drinking causes more injury - as measured by gene-expression changes - to the liver than acute or binge drinking. (Wed, 04 Feb 2009 09:52:49 GMT)
Predicting Resistance To Breast Cancer Chemotherapy Treatment
Researchers at the Swiss Institute of Bioinformatics and the Swiss National Center of Competence in Research in Molecular Oncology in Lausanne have developed a new test to predict how breast cancer patients respond to chemotherapy, which could help change how treatment is delivered in the future. (Wed, 04 Feb 2009 13:15:32 GMT)
Strengthening The Reporting Of Genetic Association Studies
Making sense of rapidly evolving evidence on genetic associations is crucial to making genuine advances in human genomics and the eventual integration of this information in the practice of medicine and public health. (Wed, 04 Feb 2009 14:18:12 GMT)
Research and Markets: New Strategies for Combating Bacterial Infection in this Essential Handbook
Research and Markets ( http://www.researchandmarkets. ) has announced the addition of John Wiley and Sons Ltd's new report " New Strategies Combating Bacterial Infection " to their offering. (Wed, 04 Feb 2009 15:19:10 GMT)
BD to Issue Dividend
NEW YORK (GenomeWeb News) – Becton Dickinson said yesterday that its board of directors has declared a quarterly dividend of $.33 per common share. The dividend is payable on March 31 to shareholders of record on March 10. (Wed, 04 Feb 2009 15:38:09 GMT)
Nasdaq Bumps DeCode from Global Market
NEW YORK (GenomeWeb News) — DeCode Genetics' stock has been moved from the Nasdaq Global Market to the Nasdaq Global Market after failing to maintain a minimum market value for listed shares, the company said today. (Wed, 04 Feb 2009 15:38:22 GMT)
Roche Posts Double-Digit Increase in Full-Year Applied Science Revenues, Dip in MDx
NEW YORK (GenomeWeb News) – Roche today reported a 3 percent increase in full-year revenues for its diagnostics division, to 9.7 billion Swiss francs ($8.4 billion) from 9.4 billion Swiss francs ($8.1 billion) in 2007. (Wed, 04 Feb 2009 15:53:19 GMT)
More Liver Injury Caused By Chronic Drinking Than Acute Or Binge Drinking
Alcohol consumption is known to cause liver damage. Yet the specifics of alcohol-induced liver injury can differ depending on the pattern of drinking. New rodent findings show that chronic drinking causes more injury - as measured by gene-expression changes - to the liver than acute or binge drinking. (Wed, 04 Feb 2009 16:18:12 GMT)
Testing, Testing, 1, 2, 3
At Bioinformatics Zen, Michael Barton wonders why he should write good software -- after all, he's not developing it for commercial use. He says, though, that the commercial principles of unit testing, automated building, and source control should be applied to scientific software development. (Wed, 04 Feb 2009 16:53:47 GMT)
1 Step Closer To Personalized Medicine: Stroma Genomic Signature Predicts Resistance To Anthracyclin-Based ...
Researchers at the Swiss Institute of Bioinformatics and the Swiss National Center of Competence in Research in Molecular Oncology in Lausanne have developed a new test to predict how breast cancer patients respond to chemotherapy, which could help change how treatment is delivered in the future. (Wed, 04 Feb 2009 17:16:21 GMT)
EMBL GeneCore purchases Genomatix's next generation sequencing data analysis solution
( Genomatix Software GmbH ) The GeneCore of the European Molecular Biology Laboratory installed a Genomatix Mining Station and a Genomatix Genome Analyzer in Heidelberg, Germany. These systems deliver a complete and integrated analysis solution for Next Generation Sequencing data that can keep pace with the abundance of high quality data being produced at the EMBL's Genomics Core. (Wed, 04 Feb 2009 17:47:47 GMT)
Scientists study Q fever pathogen
BETHESDA, Md., Feb. 4 (UPI) -- U.S. scientists say they have uncovered genetic clues about why some strains of the pathogen that causes Q fever are more virulent than others. (Wed, 04 Feb 2009 18:29:49 GMT)
Research and Markets: Animal Biotechnology - Technologies, Markets and Companies Gives Market Projections Right Up To ...
DUBLIN, Ireland----Research and Markets has announced the addition of Jain PharmaBiotech's new report "Animal Biotechnology - Technologies, Markets and Companies" to their offering. (Wed, 04 Feb 2009 18:33:00 GMT)
Scientists study Q fever pathogen
U.S. scientists say they have uncovered genetic clues about why some strains of the pathogen that causes Q fever are more virulent than others.Researchers from the National Institute of Allergy and Infectious Diseases, Texas A&M Health Center and the Virginia Bioinformatics Institute at Virginia Tech compared the sequences of four strains of Coxiella burnetii -- an intracellular bacterium that ... (Wed, 04 Feb 2009 19:12:05 GMT)
Ovarian Cancer Prognostic Signature Reveals Key Pathways
NEW YORK (GenomeWeb News) – A new prognostic gene signature for ovarian cancer, described in PloS Medicine yesterday, is revealing ovarian cancer-related pathways and transcription factors that could help researchers close in on new treatments. (Wed, 04 Feb 2009 20:38:10 GMT)
EMBL Purchases Genomatix's Software
NEW YORK (GenomeWeb News) — The European Molecular Biology Laboratory has installed genomics data mining and analysis tools from Genomatix Software in its Genomics Core Facility, the company said today. (Wed, 04 Feb 2009 20:38:39 GMT)
23andMe, MondoBiotech Collaborate to Study Genetic Risk for Rare Diseases
Consumer genomics firm 23andMe and Switzerland-based MondoBiotech are collaborating on a global research project to uncover the genetic underpinnings of rare diseases, the partners announced last week. (Wed, 04 Feb 2009 22:08:16 GMT)
New test predicts how breast cancer patients respond to chemotherapy
Researchers at the Swiss Institute of Bioinformatics and the Swiss National Center of Competence in Research in Molecular Oncology in Lausanne have developed a new test to predict how breast cancer patients respond to chemotherapy, which could help change how treatment is delivered in the future. (Wed, 04 Feb 2009 22:19:05 GMT)
Navigenics Launches Cheaper Annual Genomic Service; Will Doctors Bite?
Navigenics last week launched a cheaper, stripped-down personal-genomics service meant to be integrated into individuals’ annual checkup in hopes that physicians will incorporate the resulting genetic-risk information in everyday health decision-making. (Wed, 04 Feb 2009 22:23:09 GMT)
Mosquito genes linked to insecticide resistance may be new target in fight against malaria
( Cold Spring Harbor Laboratory ) Malaria remains one of the most serious diseases worldwide, claiming more than one million lives per year, the majority of whom are children under five years of age. Efforts to eliminate this mosquito-borne illness rely heavily on prevention measures, but there are concerns about resistance to insecticides. In a study published online today in Genome Research, ... (Wed, 04 Feb 2009 22:30:28 GMT)
Markers for diagnosis of cancer and its use
Disclosed herein are diagnostic markers CTHRC1, CANP and KIAA0101, which are overexpressed specifically in breast or colorectal cancer. A method for diagnosing the cancer by-detecting the markers, and a method for preventing or (Wed, 04 Feb 2009 22:43:20 GMT)
Diagnosis and treatment of alzheimer's and other neurodementing diseases
Isolated, monoclonal, human, anti-β-amyloid antibodies are provided which bind to dimeric forms of Ab with higher affinity than to monomeric forms of Ab and when bound to an Aβ polypeptide comprising Aβ(21-37) (Wed, 04 Feb 2009 22:43:31 GMT)
UPI NewsTrack Health and Science News
NASA scrubs weather satellite launch … Researchers find new schizophrenia gene … Japanese scientists find archaean genes … Scientists study Q fever pathogen ... Health/Science news from UPI. (Wed, 04 Feb 2009 22:44:40 GMT)
What's killing the coral reefs?
( DOE/Lawrence Berkeley National Laboratory ) A DNA microarray developed at Berkeley Lab may help scientists learn how to preserve coral, one of the ocean's most important denizens. The technology tracks changes in microbial populations that indicate coral disease. (Wed, 04 Feb 2009 22:48:49 GMT)
Chronic drinking causes more liver injury than acute or binge drinking
Alcohol consumption is known to cause liver damage. Yet the specifics of alcohol-induced liver injury can differ depending on the pattern of drinking. (Wed, 04 Feb 2009 22:48:53 GMT)
Prebys donation goes to Burnham
Malin Burnham and John Reed flank Conrad Prebys at the dedication of the Conrad Prebys Center for Chemical Genomics. Photo by: Courtesy The event was billed as "What One Man Can Do." And what the man being honored has done is a lot. A host of speakers on Jan. 29 saluted philanthropist Conrad Prebys, whose $10 million donation to Burnham Institute for Medical Research will ... (Wed, 04 Feb 2009 23:08:24 GMT)
Lenetix Launches Screening Study of New Down Syndrome Test
Lenetix, Inc. today announced the launch of an Institutional Review Board -approved screening study of an improved first and second trimester non-invasive fetal diagnostic test to detect Down syndrome. (Thu, 05 Feb 2009 09:00:00 GMT)
CLC Bio Launches Largest Software Update to Date and Now Includes Gene Expression Analyses
AARHUS, Denmark----CLC bio just launched major updates to all their workbenches, resulting in the largest software update in the company's history. Other than a wide range of new features and improvements within sequence analysis, CLC bio's two top software products CLC Main Workbench and CLC Genomics Workbench now supports a full workflow in analysis of both digital- and analogue gene ... (Thu, 05 Feb 2009 10:36:00 GMT)
CLC Bio Launches Largest Software Update to Date and Now Includes Gene Expression Analyses
CLC bio just launched major updates to all their workbenches, resulting in the largest software update in the company's history. Other than a wide range of new features and improvements within sequence analysis, CLC bio’s two top software products CLC Main Workbench and CLC Genomics Workbench now supports a full workflow in analysis of both digital- and analogue gene expression, such as ... (Thu, 05 Feb 2009 10:49:12 GMT)
Illumina Presents Development Roadmap for Scaling its Genome Analyzer
SAN DIEGO----Illumina, Inc. unveiled a development roadmap for its Genome Analyzer system that charts a path to generate greater than 95 Gigabases of high quality data per run in 2009. (Thu, 05 Feb 2009 11:00:00 GMT)
IBC's 22nd International Antibody Development & Production Conference To Anchor Biopharmaceutical Development & ...
IBC is pleased to hold its 22nd International Antibody Development & Production Conference in Carlsbad, California on March 4-6, 2009. (Thu, 05 Feb 2009 11:16:42 GMT)
Illumina Presents Development Roadmap for Scaling its Genome Analyzer
Illumina, Inc. (NASDAQ:ILMN) unveiled a development roadmap for its Genome Analyzer system that charts a path to generate greater than 95 Gigabases of high quality data per run in 2009. This roadmap, which was presented at a user-group meeting at this week’s Advances in Genome Biology and Technology (AGBT) conference, outlined advances in chemistry, algorithms, and hardware which will ... (Thu, 05 Feb 2009 11:18:59 GMT)
Webinar : 'The Brave New World Of Non-Coding RNA's'
Distinguished Guest Speaker of the febit Science Lounge Webinar: Prof. Alexander Huettenhofer Division of Genomics & RNomics at the Medical University - Biocenter in Innsbruck (Austria) Tuesday, February 10, 2009 11:00 a.m. EST (5:00 p.m. CET) Webinar Login: http://www.febit. (Thu, 05 Feb 2009 12:17:32 GMT)
Applied Biosystems Collaborates With Leading Medical Institution to Study Mechanisms of Cancer Development Using SOLiD ...
CARLSBAD, Calif.----A team of researchers from the Mayo Clinic today announced preliminary data that demonstrates the advantages of sequencing-based approaches for associating structural variants with RNA expression profiles to identify potential biomarkers in head and neck cancer. (Thu, 05 Feb 2009 12:30:00 GMT)
Applied Biosystems Collaborates With Leading Medical Institution to Study Mechanisms of Cancer Development Using SOLiD ...
A team of researchers from the Mayo Clinic today announced preliminary data that demonstrates the advantages of sequencing-based approaches for associating structural variants with RNA expression profiles to identify potential biomarkers in head and neck cancer. The data is the result of an ongoing scientific collaboration formed in 2008 between the Mayo Clinic and Applied Biosystems, a ... (Thu, 05 Feb 2009 12:49:20 GMT)
EMBL GeneCore Purchases Genomatix's Next Generation Sequencing Data Analysis Solution
Genomatix Software, a leading provider of complete solutions for the analysis of Next Generation Sequencing (NGS) data, has announced that the European Molecular Biology Laboratory (EMBL) installed a Genomatix Mining Station and a Genomatix Genome Analyzer at its Genomics Core Facility. (Thu, 05 Feb 2009 13:16:52 GMT)
Philips And Immunetrics Join Forces To Research Advanced Solutions For Infectious Disease In Critical Care
Royal Philips Electronics (NYSE: PHG, AEX: PHI) and Immunetrics Inc. announced they have entered into a joint development agreement to explore future-generation approaches to the problem of infectious disease in critical care. This announcement was made at the annual Congress of the Society of Critical Care Medicine, taking place January 31 - February 4 in Nashville, Tenn. (Thu, 05 Feb 2009 13:18:02 GMT)
Mosquito Genes Linked To Insecticide Resistance May Be New Target In Fight Against Malaria
Malaria remains one of the most serious diseases worldwide, claiming the lives of more than one million people per year in tropical and sub-tropical regions, the majority of whom are children under five years of age. Efforts to eliminate this mosquito-borne illness rely heavily on prevention measures, but there are growing concerns about resistance to insecticides. (Thu, 05 Feb 2009 15:18:13 GMT)
New FDA Effort to Take Aim at Genomics
NEW YORK (GenomeWeb News) — The US Food and Drug Administration is creating a new position at the Office of FDA's Chief Scientist that will focus on the agency's genomics-related programs, FDA said this week. (Thu, 05 Feb 2009 15:53:09 GMT)
TRADE NEWS: Agilent Technologies Introduces Target Enrichment Platform that Removes Major Bottleneck from ...
Agilent Technologies, Inc. (NYSE:A) chose the Advances in Genome Biology and Technology (AGBT) meeting to introduce the Agilent SureSelect Target Enrichment System, a unique tool for greatly streamlining DNA-sequencing research by enabling scientists to sequence only genomic areas of interest with next-generation sequencing instrumentation. (Thu, 05 Feb 2009 16:19:32 GMT)
Cytomedix Further Strengthens Its Board of Directors
ROCKVILLE, Md., Feb. 5, 2009 -- Cytomedix, Inc. announced today that it has appointed C. Eric Winzer to its Board of Directors; Mr. Winzer will also serve as Audit Committee Chairman and the Audit Committee financial expert. (Thu, 05 Feb 2009 17:10:00 GMT)
Industry Briefs
Thermo Fisher Scientific this week reported a 1-percent revenue decline in its Analytical Technologies segment during the fourth quarter of 2008 while overall receipts inched up 1 percent. (Thu, 05 Feb 2009 20:38:12 GMT)
New Products
Bioinquire this week launched ProteoIQ , version 1.2, a bioinformatics tool for proteomics data analysis. (Thu, 05 Feb 2009 20:38:19 GMT)
NIH Funding for Proteomics Fell 3 Percent in FY 2008
For the period covering Oct.1, 2007, to Sept. 30, 2008, NIH funding for proteomics research declined to $125.6 million from $129.1 million in fiscal 2007. (Thu, 05 Feb 2009 20:53:09 GMT)
Proxeon Raises $2.4M in Financing; Funds Will be Used to Build Sales and Marketing Capabilities
Building on a just-completed year in which it expects sales of its Easy-nLC platform to drive revenue growth by more than 60 percent year over year, Danish liquid-chromatography and bioinformatics firm Proxeon said this week it has secured a DKK 14 million ($2.4 million) financing round. (Thu, 05 Feb 2009 20:56:00 GMT)
Luminex Corporation Reports Fourth Quarter and Year-End 2008 Results
Luminex Corporation (NASDAQ:LMNX) today announced financial results for the fourth quarter and year ended December 31, 2008. Recent financial and operating highlights include the following: (Thu, 05 Feb 2009 21:20:20 GMT)
Genetic Study Shows Direct Link Between Vitamin D and Ms Susceptibility 'Gene'
Scientists have found evidence that a direct interaction between vitamin D and a common genetic variant alters the risk of developing multiple sclerosis (MS). (Thu, 05 Feb 2009 22:04:06 GMT)
CLC bio updates Main Workbench, Genomics Workbench
CLC bio has released several updates to its genetics software, including a major overhaul to CLC Main Workbench and a minor update to CLC Genomics Workbench. Main Workbench 5.0 now supports both microarray- and sequencing-based expression data, along with new visualization options for expression analysis, including an interactive heat map and scatter plot views. Users can work with expression ... (Fri, 06 Feb 2009 00:24:46 GMT)
DNA microarray may help reveal reason behind coral reefs' deaths
Washington, Feb 5 : Scientists have developed a DNA microarray that may shed light on coral disease, which may help them learn how to preserve coral, one of the ocean's most important denizens. (Fri, 06 Feb 2009 05:08:34 GMT)
1 2 3 4 5 Next
